COMMON STOCK | 6. COMMON STOCK a) Stock Options The Company has a rolling stock option plan (the “Plan”) whereby the Company may grant stock options to executive officers and directors, employees, and consultants at an exercise price to be determined by the board of directors, provided the exercise price is not lower than the market value on the date of grant. The Plan provides for the issuance of up to 10% of the Company’s issued common shares as at the date of grant with each stock option having a maximum term of five years. The board of directors has the exclusive power over the granting of options and their vesting provisions. Stock option transactions are summarized as follows: Number of Weighted Balance, June 30, 2016 11,465,000 $ 0.69 Granted 710,000 0.96 Exercised - - Cancelled/expired - - Balance, September 30, 2016 12,175,000 0.71 The following table summarizes the information and assumptions used to determine option costs for the three-month period ended September 30, 2016: Fair value per option granted during the period (C$) $ 0.50 Risk-free interest rate 0.75 % Expected dividend yield 0 % Expected stock price volatility (historical basis) 97.2 % Expected option life in years 2.15 The following table summarizes information about stock options outstanding at September 30, 2016: Exercise Expiry date Number Aggregate Number Aggregate $ 0.50 May 9, 2017 370,000 $ 115 370,000 $ 115 $ 0.62 January 19, 2021 5,575,000 1,059 2,787,500 530 $ 0.65 May 20, 2017 50,000 8 50,000 8 $ 0.65 July 28, 2017 1,250,000 200 1,250,000 200 $ 0.76 September 2, 2017 500,000 25 500,000 25 $ 0.80 December 22, 2017 3,220,000 32 3,220,000 32 $ 0.94 April 28, 2018 500,000 - 375,000 - $ 0.96 July 21, 2021 710,000 - - - Balance September 30, 2016 12,175,000 $ 1,439 8,552,500 $ 910 The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company’s closing stock price of C$0.81 as of September 30, 2016, which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options vested and exercisable as of September 30, 2016 was 8,177,500. As of September 30, 2016, there was $380 of unrecognized compensation cost related to unvested share-based compensation arrangements granted under the Plan. The cost is expected to be recognized over a weighted average period of approximately 1.25 years. b) Warrants Warrant transactions are summarized as follows: Warrants Weighted average Balance June 30, 2016 22,733,685 $ 0.74 Granted - - Exercised (130,229 ) 0.65 Expired - - Balance, September 30, 2016 22,603,456 $ 0.74 At September 30, 2016, the Company has outstanding exercisable warrants, as follows: Number Exercise Expiry Date 7,431,261 $ 0.65 November 10, 2016 182,910 0.85 February 27, 2017 2,714,000 1.00 February 27, 2017 3,125,000 0.72 December 22, 2018 9,150,285 0.75 January 19, 2019 22,603,456 |